Term
|
Definition
Blocks Dihydropteroate Synthase to Inhibit Folic Acid Synthesis;
G+/-, not anaerobes;
IV/oral |
|
|
Term
|
Definition
Blocks Dihydrofolate Reductase to Inhibit Folic Acid Synthesis;
G+/-, not anaerobes;
IV/oral |
|
|
Term
|
Definition
narrow spectrum B-lactam;
Binds to and inactivate PBP's to Block Peptidoglycan/Cell Wall Synthesis;
Highest activity against G+ bacteria and G- cocci, not G- enterics;
Sensitive to penicillinase (aka B-lactamase) breaks B-lactam ring IV |
|
|
Term
|
Definition
narrow spectrum B-lactam;
Binds to and inactivate PBP's to Block Peptidoglycan/Cell Wall Synthesis;
Highest activity against G+ bacteria and G- cocci, not G- enterics;
Sensitive to penicillinase (aka B-lactamase) breaks B-lactam ring;
ORAL |
|
|
Term
|
Definition
Broad spectrum B-lactam;
Binds to and inactivate PBP's to Block Peptidoglycan/Cell Wall Synthesis;
G+ and G- enteric bacilli (E.coli);
IV/Oral |
|
|
Term
|
Definition
Broad spectrum B-lactam;
Binds to and inactivate PBP's to Block Peptidoglycan/Cell Wall Synthesis;
G+ and G- enteric bacilli (E.coli);
Oral |
|
|
Term
|
Definition
Broad spectrum B-lactam;
Binds to and inactivate PBP's to Block Peptidoglycan/Cell Wall Synthesis;
1st B-lactam effective against P. aeruginosa;
IV |
|
|
Term
|
Definition
Broad spectrum B-lactam;
Binds to and inactivate PBP's to Block Peptidoglycan/Cell Wall Synthesis;
effective against P. aeruginosa;
IV |
|
|
Term
|
Definition
extended spectrum B-lactam;
Binds to and inactivate PBP's to Block Peptidoglycan/Cell Wall Synthesis;
Most active penicillin against G- enterics, P. aeruginosa, and G- anaerobes (less active against G+ cocci;
IV |
|
|
Term
|
Definition
narrow spectrum B-lactam;
Anti-Staphylococcal, not E.coli (lower activity than Pen G, but resistant to penicillinase;
Resistant (MRSA);
IV |
|
|
Term
|
Definition
narrow spectrum B-lactam;
Anti-Staphylococcal, not E.coli (lower activity than Pen G, but resistant to penicillinase;
Resistant;
IV/oral |
|
|
Term
|
Definition
narrow spectrum B-lactam;
Anti-Staphylococcal, not E.coli (lower activity than Pen G, but resistant to penicillinase;
Resistant;
IV/oral |
|
|
Term
|
Definition
narrow spectrum B-lactam;
Anti-Staphylococcal, not E.coli (lower activity than Pen G, but resistant to penicillinase;
Resistant;
Oral |
|
|
Term
|
Definition
narrow spectrum B-lactam;
Anti-Staphylococcal, not E.coli (lower activity than Pen G, but resistant to penicillinase;
Resistant;
Oral |
|
|
Term
|
Definition
| Cephalosporins differ from penicillins in having greater acid stability; being penicillinase resistant; and being antigenically dissimilar (5-15% cross reactivity in penicillin-allergic patients) |
|
|
Term
|
Definition
1st gen. cephalosporin;
G+, G- enterics, not P. aeruginosa; Sensitive to cephalosporinases;
IV/Oral |
|
|
Term
|
Definition
1st gen. cephalosporin;
G+, G- enterics, not P. aeruginosa; Sensitive to cephalosporinases;
IV/Oral |
|
|
Term
|
Definition
2nd gen cephalosporin;
Improved anaerobic activity; resistant to cephalosporinases, but sensitive to ESBL's
IV/Oral |
|
|
Term
|
Definition
2nd gen cephalosporin;
Improved anaerobic activity; resistant to cephalosporinases, but sensitive to ESBL's
IV/Oral |
|
|
Term
|
Definition
3rd gen cephalosporin;
Improved G- activity;
resistant to cephalosporinases, but sensitive to ESBL's;
IV/Oral |
|
|
Term
|
Definition
4th gen cephalosporin;
Anti-Psuedomonal and preserved activity for Streptococci;
Resistant to both cephalosporinases and ESBL's; IV/Oral |
|
|
Term
|
Definition
monobactam;
same activity as penecillins/cephalosporins;
G- activity equal to 3rd gen. cephs; no anaerobic or G+ activity
****can be used in pen-allergic patients.;
IV |
|
|
Term
|
Definition
carbapenem;
same activity as penecillins/cephalosporins etc.;
Very broad Spectrum;
G+/-, Anti-Psuedomonal, anaerobes, Strep. Pneumo;
Sensitive to carbanpenemases; also bacteria can alter porin channels decreasing permeability;
IV |
|
|
Term
|
Definition
carbapenem;
same activity as penecillins/cephalosporins etc.;
Very broad Spectrum;
G+/-, Anti-Psuedomonal, anaerobes, Strep. Pneumo;
Sensitive to carbanpenemases; also bacteria can alter porin channels decreasing permeability;
IV |
|
|
Term
|
Definition
carbapenem;
same activity as penecillins/cephalosporins etc.;
Low Pseudomonas and Acinetobacter activity;
Sensitive to carbanpenemases; also bacteria can alter porin channels decreasing permeability;
IV |
|
|
Term
|
Definition
Binds to peptidoglycan precursors to inhibit transfer of precursors to growing cell wall;
Activity restricted to G+, drug of choice for MRSA;
Resistance already occurs in Enterococcus species (source of resistance for the 1st VRSA);
IV/Oral |
|
|
Term
|
Definition
| Blocks phosphatase to inhibit carrier lipid in peptidoglycan synthesis; Topical therapy for G+ |
|
|
Term
Polymyxins;
{Polymyxin B, Polymyxin E (Colistin)} |
|
Definition
Cationic detergent-damaging cell membrane;
Topical therapy for G- rods |
|
|
Term
|
Definition
bactericidal;
Irreversibily binds cell membrane; depolarizes and causes cell death; Aerobic G+ (note that binding to pulmonary surfactant causes inactivation) |
|
|
Term
|
Definition
Disrupts proper pentapeptide formation in peptidoglycan precursors;
Anti-Tuberculosis |
|
|
Term
|
Definition
Specific binding to a 30S ribosomal protein , distorts the acceptor site and causes misreading;
Broad spectrum, not anaerobes, not intracellular bacteria;
IV |
|
|
Term
|
Definition
Specific binding to a 30S ribosomal protein , distorts the acceptor site and causes misreading;
Broad spectrum, not anaerobes, not intracellular bacteria;
IV |
|
|
Term
|
Definition
Specific binding to a 30S ribosomal protein , distorts the acceptor site and causes misreading;
Broad spectrum, not anaerobes, not intracellular bacteria;
IV |
|
|
Term
|
Definition
Specific binding to a 30S ribosomal protein , distorts the acceptor site and causes misreading;
Extended spectrum, including activity against Pseudomonas;
IV |
|
|
Term
|
Definition
Specific binding to a 30S ribosomal protein , distorts the acceptor site and causes misreading;
Extended spectrum, including activity against Pseudomonas;
IV |
|
|
Term
|
Definition
Specific binding to a 30S ribosomal protein , distorts the acceptor site and causes misreading;
Extended spectrum, including activity against Pseudomonas;
IV |
|
|
Term
|
Definition
Binds to 30S subunit to inhibit protein syn.;
Neisseria gonorrhoeae;
neither-IM |
|
|
Term
|
Definition
Blocks acceptor-site on 30S subunit to inhibit aminoacyl-tRNA binding;
broad spectrum, mycoplasma, rickettsia, chlamydia;
IV/oral |
|
|
Term
|
Definition
Blocks acceptor-site on 30S subunit to inhibit aminoacyl-tRNA binding;
broad spectrum, mycoplasma, rickettsia, chlamydia;
IV/oral |
|
|
Term
|
Definition
Blocks acceptor-site on 30S subunit to inhibit aminoacyl-tRNA binding;
broad spectrum, mycoplasma, rickettsia, chlamydia;
IV/oral |
|
|
Term
|
Definition
| a glycylcycline; Blocks acceptor-site on 30S subunit to inhibit aminoacyl-tRNA binding; broad spectrum, tetracycline resistant strains; IV/oral |
|
|
Term
|
Definition
Bind to 50S subunit to cause dissociation of tRNA and termination of peptide linking;
similar to Pen G, but includes mycoplasma and chlamydia; IV/oral |
|
|
Term
|
Definition
Bind to 50S subunit to cause dissociation of tRNA and termination of peptide linking;
similar to Pen G, but includes mycoplasma and chlamydia;
IV/oral |
|
|
Term
|
Definition
Bind to 50S subunit to cause dissociation of tRNA and termination of peptide linking;
similar to Pen G, but includes mycoplasma and chlamydia;
IV/oral |
|
|
Term
|
Definition
a ketolide;
Bind to 50S subunit to cause dissociation of tRNA and termination of peptide linking;
Resp. tract pathogens (common and atypical), Strep. pneumo., effective against B-lactam and macrolide-resistant strains;
Unable to induce MLSB resistance;
IV/oral |
|
|
Term
|
Definition
Binds to 50S to inhibit peptidyl transfer;
similar to erythromycin plus highly effective against anaerobes in general;
IV/oral |
|
|
Term
|
Definition
Binds to 50S to inhibit peptidyl transfer + affects human mitochondria; broad spectrum; IV/oral
SI: Causes bone marrow depression due to effects on human mitochondria. |
|
|
Term
|
Definition
| inhibition of proteins synthesis by binding to 50S ribosome |
|
|
Term
| Quinupristin & Dalfopristin |
|
Definition
Blocks channel in ribosome where nascent peptides exit;
G+, VRSA, VR enterococci, MRSA |
|
|
Term
|
Definition
Blocks interaction of 50S with fMet-tRNA;
G+, MRSA, VSRA, VRE, Strep. pneumo. |
|
|
Term
|
Definition
| Topical antibiotic that inhibits bacterial RNA and protein synthesis |
|
|
Term
| Imidazoles (Ketoconazole,miconazole, otrimazole) |
|
Definition
Blocks CytP-450 dependent metabolism of a precursor of ergosterol- inc. opsonization;
Less specific and have higher side effects |
|
|
Term
| Triazoles (Fluconazole, Itraconazole) |
|
Definition
Blocks CytP-450 dependent metabolism of a precursor of ergosterol- inc. opsonization;
important in patients w/ recurrent fungal infections, broader spectrum, fewer side effects; less active @ human P450 |
|
|
Term
| Echinocandins (Caspofungin) |
|
Definition
| Inhibits synthesis of 1,3-beta-D-glucan which is essential for fungal cell wall Candida, aspergillus |
|
|
Term
| Polyene Antibiotics (Amphotericin B, Nystatin) |
|
Definition
| Bind to sterols (esp. ergosterol) in cell membrane-damaging it Thrush (oral candidiasis) |
|
|
